Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bedrocan Canada is a medical cannabis company that specializes in the production of standardized, pharmaceutical-grade medicinal cannabis. Originally established as a joint venture with the Dutch firm Bedrocan International, the company introduced advanced indoor cultivation techniques and standardized strains to the Canadian healthcare market. Its products are specifically designed to provide consistent cannabinoid profiles, making them a preferred choice for clinical research and patients requiring precise dosing. In 2015, Bedrocan Canada was acquired by Tweed Marijuana Inc., which later evolved into Canopy Growth Corporation. Today, it continues to operate as a premium medical brand within the Canopy Growth portfolio, focusing on high-quality products like Bedrocan, Bedrobinol, and Bediol.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bedrocan Canada.